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WITH DIABETES MELLITUS: EVIDENCE-BASED CLINICAL
PRACTICE GUIDELINE CLINICAL
MANEJO DE LAS CRISIS GLUCÉMICAS EN PACIENTES ADULTOS CON DIABETES MELLITUS: GUÍA DE PRÁCTICA
CLÍNICA BASADA EN EVIDENCIAS
Helard Andrés Manrique Hurtado1,a, Fradis Eriberto Gil-Olivares2,b, Luis Castillo-Bravo3,c, Laura Perez-Tazzo2,b,
Giovanny Carel Campomanes-Espinoza4,b, Karina Aliaga-Llerena2,d, José Humbert Lagos-Cabrera5,b,
Alfredo Aguilar-Cartagena6,b, Guillermo E. Umpierrez7,a

ABSTRACT
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ORIGINAL
PAPER

Introduction: The manuscript summarizes the process of elaboration of the Clinical Practice Guide (CPG) for
the management of glycemic crises in adult patients with diabetes mellitus of the AUNA Clinic Network. A
multidisciplinary team of medical assistants and methodologists carried out the development of the CPG and
then there was an external review by a specialist in the field. Methods: The Elaboration Group of the CPG (GEG)
concluded on 10 PICO questions. A systematic search for CPG, systematic reviews and primary studies was carried
out to answer these PICO questions. To make recommendations we used the "GRADE-Adolopment" methodology
and the guidelines of the national regulations. Results: Ten recommendations were made (nine strong and one
weak), 18 points of good clinical practice and two flowcharts for management (one for diagnosis and the other for
the treatment of glycemic crises), 04 consensus tables on management and 01 table for surveillance and monitoring.
The topics covered by the recommendations for the management of glycemic crises were hyperglycemic crises
(glycosylated hemoglobin evaluation; b-hydroxybutyrate evaluation; insulin, potassium, 0.9% sodium chloride,
phosphorus, sodium bicarbonate treatments) and hypoglycemic crises (carbohydrate administration, monitoring,
educational program to avoid reentry). Conclusions: This article summarizes the methodology and evidence-based
recommendations of the CPG for the management of glycemic crisis in patients with diabetes mellitus in AUNA.
Key words: Diabetes mellitus; Clinical Practice Guideline; Disease management; Hypoglycemia; Hyperglycemia
(source: MeSH NLM).

RESUMEN

Introducción: El artículo resume el proceso de elaboración de la Guía de Práctica Clínica (GPC) para el manejo de las
crisis glucémicas en pacientes adultos con diabetes mellitus de la Red de Clínicas AUNA. Métodos: Las preguntas
PICO fueron priorizadas por el Grupo Elaborador de la GPC (GEG) luego de lo cual se concluyó en trabajar 10 preguntas
PICO. Para dar respuesta a las preguntas se realizó una búsqueda sistemática de GPC, revisiones sistemáticas y
estudios primarios. Se utilizó la metodología “GRADE-Adolopment” y los lineamientos de la normativa nacional
para la formulación de recomendaciones.Resultados: Se formularon 10 recomendaciones (nueve fuertes y una
débil), 18 puntos de buena práctica clínica, dos flujogramas para el manejo (uno para el diagnóstico y el otro para
el tratamiento de crisis glucémicas), 5 tablas resumen sobre el manejo y 1 tabla para la vigilancia y seguimiento. Los
temas que abarcaron las recomendaciones para el manejo de las crisis glucémicas fueron: crisis hiperglucémicas
(evaluación de hemoglobina glucosilada; evaluación de b-hidroxibutirato; tratamiento con insulina, potasio, cloruro
de sodio 0.9%, fósforo y bicarbonato de sodio) y crisis hipoglucémicas (administración de carbohidratos, monitoreo
y programa educativo para evitar el reingreso). Conclusiones: El presente artículo resume la metodología y las
recomendaciones basadas en evidencia de la GPC para el manejo de la crisis glucémica en pacientes con diabetes
mellitus de la Red de Clínicas AUNA.
Palabras clave: Diabetes mellitus; Guía de práctica clínica; Manejo de la enfermedad; Hipoglucemia; Hiperglucemia
(fuente: DeCS BIREME).
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Formation of the GEG and scope of the CPG

Diabetes mellitus is a disease with great impact
worldwide(1,2). For the year 2019, it has been estimated
that 9.3% (463 million) of the world population have
this disease(3). Its acute complications (hypoglycemia
and hyperglycemia) are a frequent cause of
admission to hospital emergency services, especially
in developing countries(4–7).

The preparation of the CPG was carried out by the
Guide Development Group (GEG). The GEG was
made up of two teams: the methodological team
of the CPG Unit and the team of doctors from the
healthcare area of the specialties of endocrinology,
internal medicine, intensive medicine, and clinical
laboratory.

In Peru, for 2015 the prevalence of diabetes mellitus
was estimated between 6.1 - 7%. Within glycemic
emergencies, ketoacidosis and hypoglycemia were
the most common (21.6%) followed by hyperosmolar
hyperglycemic state (18.2%)(5). In that year it was
approved by R.M. 719-2015 / MINSA the Technical
Guide: "Clinical Practice Guide for the Diagnosis,
Treatment, and Control of Type 2 Diabetes Mellitus
in the First Level of Care" which included some
recommendations for the management of glycemic
crises; However, in the study carried out by NeiraSánchez and Germán Málaga where their quality was
evaluated using the AGREE II instrument, scores of less
than 60% were found in all domains (The percentage
in rigor in the elaboration was 17.71%) (8.9).

The GEG decided to develop a CPG that provides
guidelines to healthcare professionals (medical
specialists, general practitioners, and other health
professionals within the scope of their competencies)
for the care of adult diabetic patients in emergency
services, intermediate care units, or critical care from
the AUNA Network clinics.

During 2019, taking into account the need to have
Clinical Practice Guidelines based on the best available
scientific evidence for the management of glycemic
crises, AUNA proposed to its Academic Scientific
Directorate that, through the Unit of Clinical Practice
Guidelines, lead the development of the Clinical
Practice Guide (CPG) for the management of glycemic
crises in adult patients with diabetes mellitus.

METHODS
The process of preparing the clinical practice
guide was developed taking into account the
methodological proposal "GRADE-Adolopment"(10,11)
and the methodological guidelines of the
national regulations(12). The GRADE-ADOLOPMENT
methodology combines the advantages of
formulating recommendations by adopting,
adapting, and formulating de novo based on
the GRADE strategy that includes, for each PICO
question proposed by the panel, a summary of the
evidence found (table “SoF”) and a paper discussion
with a multidisciplinary team called “From evidence
to recommendation” (EtD). The strategy has already
been validated by the GRADE team and has been
accepted in the construction of some clinical practice
guidelines in different countries and organizations at
the international and national levels(13-17).

https://inicib.urp.edu.pe/rfmh/vol21/iss1/7

Formulation of PICO Questions, Systematic
Search and AGREE II Evaluation
The PICO questions were selected based on the
GEG prioritization criteria. The team of specialists
decided during the panel sessions to consider the
final structure of the question. A systematic search
strategy for Clinical Practice Guidelines related to
the study topic was carried out in Medline databases
(via Pubmed), TRIP Database, Excerpta Medica
Database (EMBASE, via Ovid), Latin American and
Caribbean Literature in Health Sciences. Health
(LILACS) and Epistemonikos with no start date until
August 07, 2019. In addition, a search was carried
out in CPG compiling and compiling bodies. The
methodological quality was evaluated through two
steps: following pre-selection criteria and then the
AGREE II tool (https://www.agreetrust.org/) was used
to assess the CPGs that passed the pre-selection
criteria(18–22) (See Table 1).

ORIGINAL PAPER

INTRODUCTION

Review, synthesis, and discussion of the
evidence
The clinical questions that could be answered by
CPG recommendations that obtained a favorable
rating in the AGREE II instrument (see table 1) were
submitted to the GEG for discussion and it was
decided whether or not they would be updated.
For each of the other questions prioritized by the
specialists, a systematic search for evidence was
developed. In the case of questions answered by a
CPG, in which some modification had been made in
its structure, the adaptation of the search strategies
was considered, while in the case of questions that
had not been answered by any CPG, the procedure
was to do a de novo search. In all cases, the review
of the evidence found followed a process by
Pág. 51
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independent peers that began with a reading phase
of titles and abstracts, followed by a full-text reading
phase of the potentially relevant citations identified
in the previous phase. Any discrepancies were
resolved by consensus during the GEG sessions.

Manrique H et al

Formulation and Grading of
Recommendations
The formulation of the recommendations was carried
out during the sessions of the GEG after the review
and analysis of the evidence found (see tables 2 and

ORIGINAL PAPER

Table 1. Evaluación de calidad metodológica de las GPC de cáncer de mama usando la herramienta AGREE II

N°

Clinical Practice
Guide

Domain 1:
Scope and
objective

Domain 2:
Stakeholder involvement

Domain
3: Rigor in
Crafting

Domain 4:
Clarity of
presentation

Domain 5:
Applicability

Domain 6: Overall
Editorial evaluaindepention
dence

1

Canadian
Diabetes
Association Diabetes
Canada 2018 Clinical
Practice Guidelines for
the Prevention and Management of Diabetes
in Canada.

76%

85%

71%

96%

61%

86%

78%

2

American Diabetes Association Standards of
Medical Care in Diabetes - 2019

92%

75%

83%

89%

81%

92%

92%

3

Cenetec Diagnóstico y
tratamiento de la Cetoacidosis Diabética en
niños y adultos

94%

72%

65%

56%

60%

63%

75%

4

Cenetec Diagnóstico y
tratamiento del Estado
Hiperglucémico Hiperosmolar en adultos
con Diabetes Mellitus
tipo 2

100%

81%

71%

58%

63%

71%

75%

5

NICE Type 1 diabetes in
adults: Diagnosis and
management

75%

81%

71%

58%

67%

96%

83%

Source: self made.

3). For the grading of the recommendation (strength
and direction), the GRADE system (https://gradepro.
org/) was used, which provides 4 criteria for grading
the recommendations based on the quality of the
evidence, balance between benefits and risks, values
and preferences as well as costs and use of resources:
strong in favor (The desirable consequences
clearly outweigh the undesirable consequences.
It is recommended to do so), Weak in favor (The
desirable consequences probably outweigh the
undesirable consequences. It is suggested to do
so), Strong against (The undesirable consequences
clearly outweigh the desirable consequences. It
Pág.
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is not recommended to do so), Weak against (The
undesirable consequences probably outweigh the
desirable consequences. It is not suggested to do so)
and Good Clinical Practice (Recommended practice,
based on clinical experience and / or studies not
systematically evaluated by the GEG).

Conflicts of Interest of Participants in the GEG
To ensure the integrity and public trust in the
activities of the GEG; each one declared their conflicts
of interest according to the Form for Declaration
of Conflicts of Interest of the Technical Document:
Methodology for the Preparation of Clinical Practice
Guidelines of the Ministry of Health.
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Table 2. Recommendations made by the GEG in cases of hyperglycemic crisis with strength and direction of
the recommendation.

Recommendations

Strength and
direction

Certainty in the
evidence

1

Evaluation of glycosylated Hb in diabetic patients diagnosed with hyperglycemia
is not suggested for acute management.

Conditional
against

2

After the acute management of diabetic patients with hyperglycemia, perform a
glycosylated Hb analysis for subsequent follow-up.

BPC

Very low
(⊕⊝⊝⊝)

3

The evaluation of B-hydroxybutyrate in the blood in diabetic patients is
recommended for the diagnosis of CAD.

Strong for

4

Consider periodic monitoring (every 4 hours until resolution) of B-hydroxybutyrate
in the blood of diabetic patients found with CAD in the acute phase.

BPC

5

In diabetic patients with b-hydroxybutyrate> = 1 should be considered to rule
out CAD.

BPC

6

It is recommended to start insulin infusion doses at 0.05 - 0.1 U / Kg / h

7

Adjust the dose to 25% while achieving an average decrease of 50 mg / dL per
hour.

BPC

8

Maintain glucose values between 140 - 180 mg / dL in diabetic patients with
hyperglycemia in critical or non-critical condition.

BPC

9

It is recommended in adult diabetic patients with hyperglycemic crisis (CAD /
EHH) with marked hypokalemia (serum potassium <3.3 mmol / L), add potassium
at a dose of 10 - 20 mmol / L

Strong for

10

Avoid the administration of Potassium, if the concentration of K is> 5.2 mEq / l.

BPC

11

In adult diabetic patients with hyperglycemic crisis (CAD / HD) with normokalemia
or mild hypokalemia (serum potassium between 3.3 mmol / L to 5 mmol / L, start
intravenous potassium administration at concentrations of 10 - 20 mmol / L, at a
maximum range 20 mmol / h) once urine output is restored. Taking precaution if
the patient has kidney failure.

BPC

12

It is recommended in adult diabetic patients with hyperglycemic crisis (CAD /
EHH), initially administer 0.9% NaCl at 1000 ml / h until hypovolemic shock is
corrected, then 0.9% NaCl at 500 ml / h for 4 hours and continue at 250 mL / h.

Strong for

13

In adult diabetic patients with hyperglycemic crisis (CAD / EHH), carry out
continuous monitoring of diuresis (if necessary, place a urinary catheter).

BPC

14

Phosphorus replacement is not recommended in adult diabetic patients with
hyperglycemic crisis (CAD / EHH) and non-severe hypophosphatemia.

Strong against

15

In cases where hypophosphatemia is severe (<1 mg / dL (0.32 mmol / l), consider
its replacement.

BPC

16

In adult diabetic patients with hyperglycemic crisis (CAD / EHH) and
hypophosphatemia, monitor serum phosphorus levels.

BPC

17

The administration of sodium bicarbonate is not recommended in adult diabetic
patients with CAD with pH ≥ 6.9.

Strong against

18

It is recommended in adult diabetic patients who present severe CAD with pH
<6.9 or in shock, the administration of 50 mmol of sodium bicarbonate in 200 mL
of normal saline for one hour and continue every 1 - 2 hours until the pH is ≥ 6.9.

Strong for

19

In adult diabetic patients presenting with severe CAD with pH <6.9 or in shock
who are replaced with sodium bicarbonate, monitor serum potassium.

BPC

N°

Very low
(⊕⊝⊝⊝)

ORIGINAL PAPER

Strong for

Very low
(⊕⊝⊝⊝)

Very low
(⊕⊝⊝⊝)

Very low
(⊕⊝⊝⊝)

Very low
(⊕⊝⊝⊝)

Very low
(⊕⊝⊝⊝)

Very low
(⊕⊝⊝⊝)

Source: self made.

https://inicib.urp.edu.pe/rfmh/vol21/iss1/7

Pág. 53

4

Gil-Olivares et al.: Management of glycemic crises in adult patients with diabetes mel

Rev. Fac. Med. Hum. 2021;21(1):50-64.

Manrique H et al

Table 3. Recommendations made by the GEG in cases of hypoglycemia with strength and direction of the
recommendation.

Recommendations

Strength
and
Direction

1

Treat severe hypoglycemia in a conscious person in the emergency area
by orally ingesting 20 g of carbohydrates, preferably as glucose tablets or
equivalent (eg dilute a tablespoon of sugar in 1 glass with water or observe
the equivalent in the tables of nutritional balance of the products to be
consumed).

BPC

2

Check blood glucose values every 15 minutes and ingest another 20 g of
glucose if blood glucose remains <4.0 mmol / L (72 mg / dL).

BPC

3

Treat severe hypoglycemia in an unconscious person by intravenous
administration of 25 g (4 ampoules of 33% dextrose) of glucose administered
during the first 3 minutes.

BPC

4

In patients with severe hypoglycemia, consider a residence time of at least
24 hours.

BPC

5

In patients with severe hypoglycemia associated with complications,
consider that the hospital stay could be longer.

BPC

6

In patients with severe hypoglycemia consider monitoring capillary
blood glucose every 1-2 hours for the first 6 hours.

BPC

7

IT IS RECOMMENDED to standardize an educational program aimed at
the patient and / or family while maintaining general glycemic control
aimed at avoiding readmission for hypoglycemia.

Source in
favor

8

Include a psycho-behavioral therapeutic intervention directed towards
patients if readmissions are recurrent (> 3 times a year).

BPC

ORIGINAL PAPER

N°

Certainty
in the
evidence

Very low
(⊕⊝⊝⊝)

Source: self made.

External Review
The CPG was evaluated by an endocrinologist
specialized in the subject with expertise in the
development of clinical practice guidelines with
GRADE methodology. You were asked to declare
if you have any conflict of interest to express an
opinion on any of the issues reviewed within the CPG.
After the review, a tele-meeting was held to discuss
the suggestions submitted by the external reviewer
and conclude the final version of the clinical practice
guideline.
Implementation, monitoring of compliance with
Recommendations, and updating of the CPG
The CPG was socialized through internal meetings
and space was created on the institutional website:
https://clinicadelgado.pe/guias-de-practica-clinica/.
Through it, you can access the 2 versions of the CPG
(long version and summary version).
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To follow up on the recommendations, it was
decided to choose key recommendations on which
the indicators were built (see table 3). Said indicators
would be evaluated at 06 months and one year after
the approval of this CPG.
It was decided at the GEG meeting that the CPG
update be carried out within a period of 3 years
from the date of its publication, or when relevant
information is identified that may modify the
meaning of the clinical recommendations included.
To identify relevant information, an update of the
search strategies for the recommendations will be
developed every six months.

RECOMMENDATIONS
Hyperglycemic Crises
Seven questions were developed regarding
hyperglycemic crises. Two tables were prepared,
the first to summarize the diagnosis and severity of
5
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intervention were trivial, the certainty of the
evidence very low, we did not find any costeffectiveness studies for the intervention.
Therefore, it was concluded that the strength
and direction of the recommendation are
"Conditional Against".

hyperglycemic crises and the second to establish
criteria for electrolyte administration (see Table 4
and Table 5). Further; Two figures were prepared, 1
figure that included the diagnosis of hyperglycemic
crises and 1 figure that included the treatment of
hyperglycemic crises (see figure 1 and figure 2)
•

Question 1: In adult diabetic patients
with glucose disorders, what is the
usefulness of requesting glycated Hb
for the management of acute glucose
disorders?

•

Evidence Summary

Evidence Summary

A systematic search was carried out which
concluded in the review of 03 articles for
full text (no systematic reviews were found).
Two were excluded because they did not
include a diabetic patient population or did
not specify it as part of the study(26,27). The
study of Magee MF. et al. 2011(28), is a cohort
study in which 86 patients were analyzed, of
which 81% of the participants completed 2
visits, 67% completed 3 visits where repeated
A1C measurements were obtained, and
60% completed all 4 visits. Mean glycemia
decreased from 356 ± 110 mg / dl at the
beginning of the study to 183 ± 103 mg / dl at
4 weeks, representing an average reduction of
173.5 mg / dl (p <0.001 for the paired t-test).
There were zero cases of hypoglycemia on
day 1, and overall hypoglycemia rates were
low (1.3%). At the start of the study, 50% of
the A1C values were> 13%. The mean A1C at
the start of the study was 12% ± 1.5%. In the
46 subjects for whom A1C was obtained at
baseline and at 2 weeks, A1C had decreased
by 0.4% at the 2-week visit to 11.6% ± 1.6% (p
= 0.05 for Wilcoxon's signed range test ).

From Evidence to Recommendation
The GEG considered the use of
B-hydroxybutyrate in blood in diabetic
patients important because the evidence
supports the benefits of b-hydroxybutyrate
tests over urine acetoacetate tests to reduce
the frequency of hospitalization and reduce
the costs of care to detect the resolution
of ketosis in a more timely manner, that
the resources are available to perform the
test, that the intervention is accepted by
the GEG and that its implementation at the
institutional level is feasible. It was concluded
as a “Strong in favor” recommendation. In
addition, a table was prepared that contains
criteria to establish the diagnosis and severity
of diabetic ketoacidosis and hyperosmolar
hyperglycemic state in which ketone bodies
are included (see Table 4).

From Evidence to Recommendation

https://inicib.urp.edu.pe/rfmh/vol21/iss1/7
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In the systematic search, two systematic
reviews were found(29,30). Brooke's systematic
review was excluded because it used capillary
blood in its evaluation and the GEG considered
that studies, where the sampling was not
capillary, should be included. The study by
Klocker et al. included 4 studies(31–34) which
were reviewed in full text. It was shown that
the hydroxybutyrate blood test compared to
the hydroxybutyrate urine test is associated
with a reduced frequency of hospitalization
and shorter recovery time from diabetic
ketoacidosis. The blood ketone test is also
associated with lower costs and greater
patient/caregiver satisfaction.

HbA1c (glycated hemoglobin) is a test used
for the diagnosis and monitoring of diabetes
and prediabetes(23,24). Generally reliable as an
indicator of chronic blood glucose, it may be
inaccurate in the presence of abnormal red
blood cells, hemoglobinopathy, or another
disorder that affects red blood cells(25).

The GEG concluded that the use of HbA1c
does not support the diagnosis of glycemic
crises, although it is useful for monitoring the
patient after it has already been stabilized.
Furthermore, the undesirable effects of the

Question 2: In adult diabetic patients
with glucose disorders, what is the use
of requesting ketone bodies for the
management of acute glucose disorders?

•

Question 3: In an adult patient
with diabetes with a diagnosis of
Hyperosmolar Hyperglycemic State /
Diabetic Ketoacidosis (EHH / CAD), what
is the most useful dose of insulin to
manage hyperglycemia?
Pág. 55
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Evidence Summary
A systematic search was carried out that
concluded in the review of 2 articles for full
text (no systematic reviews were found)(35,36).
The study by Andrade-Castellanos et al was
excluded because in the full-text review the

Manrique H et al

GEG showed that it did not answer the PICO
question posed. The Firestone et al study
evaluated a total of 4393 blood glucose
readings. For the primary efficacy outcome,
hospital stay was reduced from 149.9 ± 134.4
to 114.4 ± 103.1hr (p = 0.039). There was a

Table 4 . Recommendations made by the GEG in cases of hypoglycemia with strength and direction of the

recommendation.

Expected
value
(At 6
months)

Biannual
goal

Process

Diabetic patients with hyperglycemic criPercentage of diabetic patients
ses seen in emergencies with B-hydroxywith hyperglycemic seizures
butyrate blood test results / Total Diabetic
with B-hydroxybutyrate blood
patients with hyperglycemic crises seen in
test evaluation
emergencies

> 60%

100%

Process

Percentage of diabetic patients
with a glycemic crisis who have
been stabilized in a maximum
time of 24 hours

Diabetic patients with glycemic crisis who
have been stabilized in a maximum time of
24 hours / Total diabetic patients who have
been admitted for glycemic crisis

> 60%

> 80%

Process

Number of hypoglycemic events that have
Percentage of hypoglycemic occurred during the management of hyperevents in diabetic patients ad- glycemic seizures / Total measurements
mitted for hyperglycemic crisis performed in diabetic patients who have
been admitted for hyperglycemic seizures

< 5%

< 2%

Process

Percentage of diabetic patients
admitted to the emergency
room due to hypoglycemic crisis and have received the educational program

Diabetic patient admitted to the emergency room due to a glycemic crisis and received the educational program / Total number of patients admitted to the emergency
room due to a glycemic crisis

> 60%

> 80%

Result

Percentage of diabetic patients who are readmitted due
to hypoglycemia after having
received the educational program

Diabetic patients with hypoglycemia who
received the educational program and
have been readmitted to the emergency
department in the last 3 months / Total
diabetic patients with hypoglycemic crisis
treated in the emergency room

< 20 %

< 10%

ORIGINAL PAPER

Indicator
Type

Indicator

Indicator Formula

Fuente: Elaboración propia.

decrease in the median hospital stay of 102.2
hours (interquartile range [IQR], 68.8-171.4
hours) in the group that received highly
intensive insulin therapy at 92.4 hours (IQR,
60.4–131.4hr) in the group that received
moderately intensive insulin therapy (p
<0.001). The relative risk (RR) of staying in
hospital on day 7 (0.51; 95% CI, 0.29–0.91; p
= 0.022) and day 14 (0.28; 95% CI, 0.080–0.97;
Pág.
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p = 0.044) were significantly reduced by the
moderate-intensity insulin therapy strategy.

From Evidence to Recommendation
The GEG considered, based on the balance
of the effects in favor of moderate-intensity
insulin therapy, the availability and ease of its
implementation, and that all the participants
of the GEG accepted the intervention, to start
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the insulin infusion dose low (0.05 - 0.1 U / Kg /
h). In addition, gradually adjust the insulin dose
until the patient with a hyperglycemic crisis
comes out of critical condition and stabilizes
their glucose levels. It was concluded in the
strength and direction of “Strong in favor”.
•

Question 4: In adult patients with
diabetes with a diagnosis of HHD / CAD
with a K value <= 3.3, what is the most
useful dose of potassium replacement to
treat hypokalemia?

From Evidence to Recommendation
The GEG concluded in a recommendation
“strong in favor” of administering potassium at
a dose of 10 - 20 mmol / L if serum potassium
<3.3 mmol / L because the intervention was
accepted by the entire GEG, it is feasible to
implement and that no extra resources are
required for its implementation. Also, as points
of good clinical practice: avoid potassium
administration if K is> 5.2 mEq / l and stop
insulin administration (see table 5).

Question 5: In an adult patient with
diabetes with a diagnosis of HHD /
CAD, what is the most useful dose of
electrolyte solution (fluid therapy) to
treat the disorder?
Evidence Summary
The systematic search concluded in the
review of 04 articles for full text (no systematic
reviews were found). All articles were
excluded for not answering the PICO question
posed. The evidence was obtained from the
Canadian Clinical Practice Guidelines(18) and
the American Diabetes Association's Clinical
Practice Guidelines(19) and the studies by

https://inicib.urp.edu.pe/rfmh/vol21/iss1/7

From Evidence to Recommendation
Taking into account the CPGs and the primary
studies analyzed and that during the panel
discussion it was evidenced that the balance
was in favor of the administration of 0.9%
NaCl at 1 L / h, that there was no considerable
variation in both the required resources and
the in the feasibility of its implementation
and that the GEG was unanimously in favor of
considering the intervention, it was concluded
in a recommendation “strong in favor”
regarding the administration of NaCl 0.9% at
1 L / h until correcting the hypovolemic shock
and a point of good clinical practice.
•

ORIGINAL PAPER

The systematic search concluded in the review
of 10 articles for full text (no systematic reviews
were found). All articles were excluded for
not answering the PICO question posed. The
Canadian Clinical Practice Guidelines(18) were
used and the study by Kitabchi(37) and the
study by Chiasson(38) was reviewed. In these
manuscripts, doses between 10-40 mmol / L
of potassium administration are established
to control hypokalemia and points to take into
account potassium levels in the blood. After
analyzing the CPG studies, the GEG decided to
adopt a recommendation and also establish
02 points of good practice.

•

Adrogué(39) and Fein(40) were extracted. The first
study concludes that a moderate and cautious
administration of fluid therapy is necessary
since it allows faster recovery, cost reduction,
and reduction of harmful effects. In the second
it is concluded that the administration of fluid
therapy at large volumes seems to lead to
a hypooncotic state that could cause both
subclinical cerebral edema and pulmonary
edema.

Question 6: In adult patients with
diabetes who are diagnosed with HHE
/ CAD with hypophosphatemia, what
is the most useful dose of Phosphorus
Replacement to treat the disorder?
Evidence Summary
A systematic search was carried out where
236 studies were identified which were
removed after the title and abstract review
for not answering the PICO question. The
evidence was obtained from the Canadian
Clinical Practice Guidelines(18) where Fisher's
study was found(41). In this study, the effect of
phosphate as an intermediate for oxygenation
of tissues was evaluated. Thirty patients were
studied who were divided into two groups
to determine the effect of phosphate on
2,3-DPG, dissociation of oxyhemoglobin,
serum levels of phosphorus, calcium, lactate,
pyruvate, and electrolytes, and the response
in the values of glucose, bicarbonate, and pH.
The study concluded that phosphate therapy
could accelerate erythrocyte regeneration in
a small number of the patients studied and
that this could not demonstrate an influence
on tissue oxygenation or an improvement in
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the certainty of the evidence; however, it was
decided that it should not be administered.

clinical response; in addition, an exaggerated
increase in hypocalcemia was evidenced in
patients treated with phosphorus, which
leads to great caution when using phosphate
as therapy.

From Evidence to Recommendation
The GEG analyzed the balance of the
intervention and taking into account the risks
unanimously concluded in a recommendation
“Strong against” for cases where the pH <6.9
(because the population included in the
studies of the systematic review had these
characteristics). In addition, a point of good
clinical practice was established (see Table 5).

From Evidence to Recommendation

ORIGINAL PAPER

The GEG considered evaluating the balance
against what was reported by the study, taking
into account the risk of the administration of
the drug and unanimously with respect to the
risks of the intervention concluded in adopting
the recommendation and graduating it as
"strong against". Two points of good clinical
practice were raised (see Table 5).
•

Question 7: In adult patients with
diabetes mellitus with a diagnosis of
CAD, what is the most useful replacement
dose of HCO + to treat the disorder?
Evidence Summary
The systematic search concluded in the
review of 2 articles for full text (no systematic
reviews were found). The two articles were
excluded for not answering the PICO question
posed. We worked with the Canadian Clinical
Practice Guide from which Chua's systematic
review(42) was extracted. The systematic review
evaluated the efficacy and risks associated
with the administration of bicarbonate in
the emergency treatment of severe acidemic
events in patients with diabetic ketoacidosis.
They reviewed 508 potential studies of which
they included 44 studies of which 3 were
controlled clinical trials in the adult population.
In addition, a marked heterogeneity in the
pH, concentration, amount, and time of
administration of bicarbonate was identified
between studies. In 2 of the clinical trials
reviewed, an improvement in metabolic
acidosis was demonstrated with the initial
treatment of bicarbonate in the first 02 hours.
On the other hand, there was no evidence of
improvement in glucose controls or clinical
efficacy. An increase in the risk of cerebral
edema and prolonged hospitalization time
was not found in children who received
bicarbonate, the need for potassium
supplementation was increased in these
patients. No differentiation of type 1 diabetics
or type 2 diabetics with diabetic ketoacidosis
was reported, which caused the panel to lower
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Hypoglycemia
3 questions were raised regarding hypoglycemia. A
table was prepared that summarizes the diagnosis
and severity of hypoglycemia (see Table 6). Further; a
figure was prepared that included a summary of the
diagnosis and management of hypoglycemia (see
figure 1).
•

Question 8: In adult diabetic patients
with severe hypoglycemia, what is the
most useful dose of glucose (dextrose) to
treat severe hypoglycemia?
Evidence Summary
A systematic search was carried out which
concluded in the review of 3 articles for full
text (no systematic reviews were found). All
articles were excluded for not answering
the PICO question posed. We worked with
the evidence from the Canadian Clinical
Practice Guidelines(18) whereby consensus
on the adopted recommendation was
raised. Regarding the definition of severe
hypoglycemia, it was decided that it would
obey clinical criteria or laboratory values as
specified in Table 6.

From Evidence to Recommendation
Although no primary studies or systematic
reviews were found to answer the question,
taking into account the information found
in the CPG during the discussion, the GEG
considered the intravenous treatment of
severe hypoglycemia in an unconscious
person with intravenous administration of 25
g (4 ampoules of 33% dextrose). Regarding
the route of administration, some experts
considered the term "severe" to be when there
is a loss of consciousness, despite not having
found evidence to support it necessarily and

9

Revista de la Facultad de Medicina Humana, Vol. 21 [2021], Iss. 1,
Art. 7
Manejo de las crisis glucémicas en pacientes

Rev. Fac. Med. Hum. 2021;21(1):50-64.

•

Question 8: In adult diabetic patients
with severe hypoglycemia, what is the
most useful dose of glucose (dextrose) to
treat severe hypoglycemia?
Resumen de la Evidencia
A systematic search was carried out which
concluded in the review of 3 articles for full
text (no systematic reviews were found). All
articles were excluded for not answering
the PICO question posed. We worked with
the evidence from the Canadian Clinical
Practice Guidelines(18) whereby consensus
on the adopted recommendation was
raised. Regarding the definition of severe
hypoglycemia, it was decided that it would
obey clinical criteria or laboratory values as
specified in Table 6.

From Evidence to Recommendation
Although no primary studies or systematic
reviews were found to answer the question,
taking into account the information found
in the CPG during the discussion, the GEG
considered the intravenous treatment of
severe hypoglycemia in an unconscious
person with intravenous administration of 25
g (4 ampoules of 33% dextrose). Regarding
the route of administration, some experts
considered the term "severe" to be when there
is a loss of consciousness, despite not having
found evidence to support it necessarily and
that some patients may find themselves with
severe hypoglycemia (Glucose <2.8 mg/dl)
without being unconscious. If conscious, the
GEG considered it necessary to specify that
glucose administration is oral. Three points of
good practice were formulated.
•

Question 9: In adult diabetic patients
with hypoglycemia, what is the time that
they must remain under observation
before being discharged?
Evidence Summary
A systematic search was carried out which
concluded in the review of 3 articles for full

https://inicib.urp.edu.pe/rfmh/vol21/iss1/7

ORIGINAL PAPER

text (no systematic reviews were found). All
articles were excluded for not answering the
PICO question posed. The Canadian Clinical
Practice Guide(18) was used and the study by
Tan H. K.(43) was reviewed. In the latter, 9550
patients were analyzed in the 6 months: 138
patients with diabetes (9.5%) and 70 patients
(2.7%) without diabetes, who had had an
episode of hypoglycemia and had been cared
for in the unit. medical evaluation. Patients
with diabetes and hypoglycemia at admission
had a significantly longer stay (mean SD) (10.3
11.2 vs. 7.3 9.5 days, P = 0.001) and a higher
in-hospital mortality rate (14.5 vs. 5.2%, P
<0.001) in comparison with those without
hypoglycemia Patients without diabetes with
hypoglycemia had a longer stay (mean SD)
(9.1 10.5 vs. 6.7 9.9 days, P = 0.05) and a higher
hospital mortality rate (24.3 vs. 5.4%, P <0.001)
compared to those without hypoglycemia.
In conclusion, hypoglycemia is associated
with a longer duration of hospitalization and
an increase in the hospital mortality rate.
Hypoglycemia may have contributed to the
worse outcome, but it also appears to be a
marker of the severity of the disease in poorly
controlled patients, especially patients with
sepsis.

that some patients may find themselves with
severe hypoglycemia (Glucose <2.8 mg/dl)
without being unconscious. If conscious, the
GEG considered it necessary to specify that
glucose administration is oral. Three points of
good practice were formulated.

From Evidence to Recommendation
After the analysis, the GEG concluded that
because no direct evidence was found to
support issuing a recommendation in this
regard and that both the aforementioned
study and the Canadian CPG show the need for
better surveillance in hypoglycemic patients
admitted by emergency that It is necessary
to consider three points of good practice that
were included in the CPG.
•

Question 10: In adult diabetic patients
with hypoglycemia, what is the usefulness
of individualized educational therapy to
prevent readmission for hypoglycemia at
discharge?
Evidence Summary
A systematic search was carried out which
concluded in the review of 5 articles for full
text (no systematic reviews were found). 04
studies(44–47) were excluded for not answering
the PICO question. The study by Cox D.(48) was
included, which evaluated 60 adults with
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DM1 and a history of ≥ 2 episodes of severe
hypoglycemia (inability to treat oneself due
to hypoglycemic stupor or unconsciousness)
for 6 consecutive months. It was concluded
that patients with hypoglycemia anticipation,
awareness, and treatment training (HAATT)
were able to reduce the occurrence of
hypoglycemia, as reflected in three different
parameters: low glycemic index, lower mean
glycemic reading, and glycemic percentage
< 3.9 mmol / L. Because the population was
small and only patients with type 1 diabetes
mellitus were included, a very low certainty of
the evidence was established.

Manrique H et al

From Evidence to Recommendation
Based on the evidence and the discussion of
the GEG that included the balance in favor of
the intervention, the unanimity in including
the intervention, its low cost and feasibility
in the implementation (both since it would
not involve an extra cost to standardize the
program such as training a group of nursing
or psychology professionals to provide
therapy), it was concluded to recommend the
standardization of the educational program
as a “strong in favor” recommendation and
add a point of good clinical practice

Table 5. Criteria for the diagnosis and severity of diabetic ketoacidosis and hyperosmolar hyperglycemic state
in diabetic patients.
Hyperosmolar
state

Cetoacidosis Diabética
Criterios
Diagnósticos

Mild (Plasma
Glucose> = 250 mg
/ dl)

Moderate (Plasma
Glucose> = 250 mg
/ dl)

Arterial Ph

7,25-7,30

7,00 a <7,25

<7,00

>7,30

Anion Gap

>10

>12

>12

Variable

Variable

Variable

Variable

>320 mOsm/Kg

15-18 mEq /L

10-<15 mEq /L

<10 mEq /L

>18 mEq /L

Positive

Positive

Positive

Slightly positive

Alert

Alert / Sleep

Stupor / Coma

Stupor / Coma

Blood Osmolarity

Bicarbonate of Blood

Ketonic Bodies in
Blood / Urine

Neurological Status

Severe (Plasma
(Plasma Glucose> =
Glucose> = 250 mg
600 mg / dl)
/ dl)

Source: Prepared based on the translated criteria of Kitabchi AE, Umpierrez GE. Hyperglycemic crises in adult patients with diabetes. ADA. 2009;
32 (7): 1336.
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Table 6. Criteria for the administration of electrolytes (potassium, phosphorus and bicarbonate) in diabetic
ketoacidosis and hyperosmolar hyperglycemic state.

Standard to start administration
Diagnostic criteria

Match

Diabetic cetoacidosis

Hyperosmolar hyperglycemic
state

Consider phosphate replacement if serum phosphate <1 mg
Limit phosphorus replacement to
/ dL (0.32 mmol / L) (also consider
persistent hypophosphatemia (afphosphate replacement in pater the acute phase has elapsed).
tients with cardiac dysfunction,
anemia, or respiratory distress)

Potassium

Baking soda

If K ≥ 3.3 mEq / L and K <5.2 mEq / L Potassium is usually elevated, ge(5.2 mmol / L); replenish potassium nerally due to extracellular chanas recommended
ge caused by insulin deficiency,
hypertonicity, and acidemia.
If K <3.3 mEq / L (3.3 mmol / L) replaces potassium earlier as recommended before starting insulin
therapy.
Replenish usually if the pH is less
than 6.9. (Consider replacement in
special conditions such as vascular
collapse or cardiac arrhythmias)

ORIGINAL PAPER

If K ≥ 5.2 mEq / L (5.2 mmol / L), no
replacement but continuous monitoring every 2 hours.

It does not require

Source: Elaborated based on the translated criteria Kitabchi AE, Umpierrez GE. Hyperglycemic crises in adult patients with diabetes. ADA. 2009;
32 (7): 1336.

Table 7. Criteria for the diagnosis and severity of hypoglycemia in diabetic patients.
Mild (level 1)

Moderator (level 2)

Severe (level 3)

Autonomic signs: tremor, palpita- Autonomic and neuroglycopenic It could be unconscious.
tions, sweating, anxiety, nausea pre- symptoms (Difficulty concentrating, Severe event characterized by mensent and / or
Confusion, weakness, drowsiness, tal and physical alterations and / or
vision changes, headache, dizziness)
present and / or

Glucose minus 70 mg / dL and ≧ 54 Glucose <54 mg / dL. (3 mmol / L)
mg / dL. (3.9 mmol / L)

https://inicib.urp.edu.pe/rfmh/vol21/iss1/7

Glucose usually less than 50 mg / dL.
(2.8 mmol)
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Diabetic patients enter the
emergency room with autonomic
signs with or without loss of
consciousness

Measure
Glucose

Glucose <70 mg / dl

Glucose> = 250 mg / d

Hypoglycemia

AGA and
B-hydroxybutyrate
in blood

Set severity

Hyperglycemic
crisis

ORIGINAL PAPER

Glucose <54 mg / dl) or loss of consciousness

Non-severe hypoglycemia
(Mild - Moderate)

Severe
Hypoglycemia

Diabetic
cetoacidosis

Conscious patients, oral intake of
20 g. carbohydrates.

Oral intake of
simple
carbohydrates

Hyperosmolar
Hyperglycemic
State

Unconscious patients,
intravenous administration of
25 g. glucose

24-hour monitoring
and educational
intervention

Figure 1. Flow chart for the diagnosis of glycemic crisis in diabetic patients.

Hyperglycemic crisis

Intravenous
insulin

k + serum

Severe
dehydration
< 3,3 mmol/L)

Start insulin
infusion doses at
0.05 - 0.1 U / Kg /
h and adjust dose
according to
evolution. If
administration by
infusion is not
possible,
administer 0.1 U /
Kg of intravenous
bolus insulin

Initially
administer 0.9%
NaCl at 1 L / h
until hypovolemic
shock is
corrected, then
0.9% NaCl at 500
mL / h for 4 hours
and continue at
250 mL / h

Stop insulin
administration.
Administer
potassium
electrolytes of
20-40 mmol / h
centrally

Serum P +

between 3.3 mmol / L to 5 mmol / L
<1 mg / dL

Administer
potassium
intravenously at
concentrations of
10-40 mmol / L, at
a maximum range
of 40 mmol / h

Consider your
replacement

Baking soda
Be rich

pH < 6,9 o en shock

Administer 50 mmol of
sodium bicarbonate in 200
mL of sterile water for one
hour and continue every 1-2
hours with AGA control and
e-until the pH is ≥ 6.9. In
EHH it is not required

Figure 2. Flow chart for the treatment of glycemic crises in diabetic patients.
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